Retatrutide

$65.00 – $200.00

Retatrutide is a novel investigational peptide that combines GLP-1, GIP, and glucagon receptor agonism, studied for its potential in metabolic health and weight management research.

Note: Retatrutide is intended for research purposes only and is not approved for human consumption or use.

Size

Clear

Retatrutide is a cutting-edge investigational peptide designed as a triple agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This unique mechanism of action has garnered significant interest in research exploring its potential benefits in metabolic health, including glucose regulation, weight management, and improved lipid profiles.

Preliminary studies have shown promise in its ability to support enhanced metabolic processes, improved energy expenditure, and appetite modulation. As a multifunctional peptide, Retatrutide offers a new frontier in understanding the complex interactions between hormones and metabolic pathways.

Note: Retatrutide is intended for research purposes only and is not approved for human consumption or use.